PharmaShots | Incisive News in 3 Shots

Subscribe Now

hibercell

HiberCell’s HC-7366 Gains the US FDA’s Fast Track Designation for Treating Acute Myeloid Leukemia (AML)

HiberCell’s HC-7366 Gains the US FDA’s Fast Track Designation for Treating Acute Myeloid Leukemia (AML)

October 24, 2024

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us